Means And Methods For The Prediction Of Joint Destruction

Full-text?

The full document isn't yet available to us from the patent office.

Abstract

The present invention relates to a method of diagnosing and/or predicting joint destruction, early joint destruction and/or accelerated joint destruction in particular, in rheumatoid arthritis, comprising determining in a sample obtained from an individual the presence of at least one nucleic acid sequence encoding an IL-4 receptor (IL-4R) which contains a mutation in position 465 of the nucleotide sequence of the wild-type IL4R as shown in SEQ ID NO: 1, whereby at said position the nucleotide A is replaced or a nucleic acid sequence encoding an IL-4 receptor (IL-4R), said IL-4R comprising at position 75 as shown in SEQ ID NO: 2 a valine instead of an isoleucine. Furthermore, the invention provides for a method of diagnosing and/or predicting early joint destruction and/or accelerated joint destruction comprising determining in a sample obtained from an individual the presence of an encoded IL-4 receptor (IL-4R) which comprises at the homologous position 75 of IL-4 receptor as depicted in SEQ ID NO: 2 a mutation, said mutation comprising the exchange from an isoleucine to a valine. In addition, the present invention relates to a use of specific probes and/or primers for the preparation of a diagnostic composition for diagnosing and/or predicting early joint destruction and/or accelerated joint destruction in particular in rheumatoid arthritis.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Oct 26, 2011
  • Application: Oct 12, 2006
    EP EP 11172855 A
  • Priority: Oct 12, 2006
    EP EP 06806238 A
  • Priority: Oct 12, 2006
    EP EP 11172855 A
  • Priority: Oct 13, 2005
    EP EP 05022344 A

Download Citation


Sign in to the Lens

Feedback